A double-blind, placebo-controlled study of rabeprazole 20 mg maintenance intermittent therapy following acute treatment in patients with symptomatic gastroesophageal reflux disease.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 18 Jun 2013

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

02 Feb 2010 Results have been published in Alimentary Pharmacology and Therapeutics.
17 Dec 2009 Actual patient number (200) added as reported by ClinicalTrials.gov.
17 Jul 2008 The actual completion date for this trial has been identified as June 2008, as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com